103 results on '"Noh, Young Su"'
Search Results
2. ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma
3. Effect of lanthanum group promoters on Cu/(mixture of ZnO and Zn-Al-spinnel-oxides) catalyst for methanol synthesis by hydrogenation of CO and CO2 mixtures
4. Dry reforming of methane over Ni/ZrO2-Al2O3 catalysts: Effect of preparation methods
5. Effect of catalytic reactor bed dilution on product distribution for Fischer-Tropsch synthesis over Ru/Co/Al2O3 catalyst
6. Combined steam and CO2 reforming of methane over La1-xSrxNiO3 perovskite oxides
7. Hydrocracking of FT-wax to fuels over non-noble metal catalysts
8. Studies on the synthesis of higher alcohol over modified Cu/ZnO/Al2O3 catalyst
9. Studies on the steam CO2 reforming of methane over ordered mesoporous nickel–magnesium–alumina catalysts
10. Hydrogenation of CO2 to synthetic natural gas over supported nickel catalyst: effect of support on methane selectivity
11. Synthesis and characterization of Al-modified SBA-15 for Fischer–Tropsch synthesis (FTS) reaction
12. CO/CO2 hydrogenation for the production of lighter hydrocarbons over SAPO-34 modified hybrid FTS catalysts
13. Hydrogenation of dibenzyltoluene and the catalytic performance of Pt/Al 2 O 3with various Pt loadings for hydrogen production from perhydro‐dibenzyltoluene
14. Development of A 360kW Bi-directional Battery Tester with Wide Voltage Output Range
15. Control Strategy of Resonant Load Identification for Free Zone Induction Heating Systems with WBG-based Multiple Inverters
16. A phase Ib trial of belvarafenib in combination with cobimetinib in patients with advanced solid tumors: Interim results of dose-escalation and patients with NRAS-mutant melanoma of dose-expansion.
17. Olmutinib in T790M‐positive non–small cell lung cancer after failure of first‐line epidermal growth factor receptor‐tyrosine kinase inhibitor therapy: A global, phase 2 study
18. Hydrogenation of dibenzyltoluene and the catalytic performance of Pt/Al2O3 with various Pt loadings for hydrogen production from perhydro‐dibenzyltoluene.
19. Arvelexin from Brassica rapa suppresses NF-κB-regulated pro-inflammatory gene expression by inhibiting activation of IκB kinase
20. Preparation and Characterization of Ni/ZrTiAlOx Catalyst via Sol-Gel and Impregnation Methods for Low Temperature Dry Reforming of Methane
21. HM43239, a Novel Small Molecule Inhibitor of FLT3, in Acute Myeloid Leukemia (AML) with and without FMS-like Tyrosine Kinase 3 (FLT3) Mutations: Phase 1/2 Study
22. A Review on Catalysts Development for Steam Reforming of Biodiesel Derived Glycerol; Promoters and Supports
23. Studies on the Fischer-Tropsch synthesis over RuCo/SiC-Al2O3 structured catalyst
24. Characterizations and Kinetic Studies for the Fischer Tropsch Synthesis Over Co/Al2O3 Catalyst
25. HM43239, a Novel Potent Small Molecule FLT3 Inhibitor, in Acute Myeloid Leukemia (AML) with FMS-like Tyrosine Kinase 3 (FLT3) Mutations: Phase 1 /2 Study
26. Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial
27. Hydrogen production by steam reforming of methane over nickel based structured catalysts supported on calcium aluminate modified SiC
28. Caffeoyloxy-5,6-dihydro-4-methyl-(2H)-pyran-2-one isolated from the leaves of Olinia usambarensis attenuates LPS-induced inflammatory mediators by inactivating AP-1 and NF-κB
29. A safety, pharmacokinetic, pharmacogenomic and population pharmacokinetic analysis of the third‐generation EGFR TKI, olmutinib (HM61713), after single oral administration in healthy volunteers
30. Belvarafenib, a novel pan-RAF inhibitor, in solid tumor patients harboring BRAF, KRAS, or NRAS mutations: Phase I study.
31. Pharmacokinetics and bioequivalence of two fenofibrate choline formulations in healthy subjects under fed and fasted condition
32. ARAFmutations confer resistance to the RAF inhibitor belvarafenib in melanoma
33. Dry reforming of methane over Ni/ZrO 2 -Al 2 O 3 catalysts: Effect of preparation methods
34. Effect of catalytic reactor bed dilution on product distribution for Fischer-Tropsch synthesis over Ru/Co/Al 2 O 3 catalyst
35. Nickel Supported on Mesoporous Alumina for Dry Reforming of Methane: Combustion Method
36. Development of a simple and sensitive HPLC-MS/MS method for determination of diazepam in human plasma and its application to a bioequivalence study
37. Hydrogenation of CO2 to synthetic natural gas over supported nickel catalyst: effect of support on methane selectivity
38. Characterizations and Kinetic Studies for the Fischer Tropsch Synthesis Over Co/Al2O3 Catalyst
39. First-in-human study of HM95573, a novel oral RAF inhibitor, in patients with solid tumors.
40. The Effect of Fe in Perovskite Catalysts for Steam CO2 Reforming of Methane
41. Studies on the synthesis of higher alcohol over modified Cu/ZnO/Al2O3 catalyst.
42. Studies on the steam CO reforming of methane over ordered mesoporous nickel-magnesium-alumina catalysts.
43. Anti-inflammatory and anti-arthritic effects of new synthetic 3-(4-hydroxyphenyl)-4-(4-thiomethoxyphenyl)-1H-pyrrole-2,5-dione
44. Synthesis and characterization of Al-modified SBA-15 for Fischer–Tropsch synthesis (FTS) reaction
45. Steam CO 2 reforming of methane over La 1−x Ce x NiO 3 perovskite catalysts
46. Hydrogen production by steam reforming of methane over mixed Ni/MgAl + CrFe 3 O 4 catalysts
47. The effect of promoters in La 0.9 M 0.1 Ni 0.5 Fe 0.5 O 3 (M = Sr, Ca) perovskite catalysts on dry reforming of methane
48. Anti-inflammatory Effects of the Methanol Extract of Polytrichum Commune via NF-κB Inactivation in RAW 264.7 Macrophage Cells
49. The effect of promoters in La0.9M0.1Ni0.5Fe0.5O3 (M = Sr, Ca) perovskite catalysts on dry reforming of methane.
50. Preparation and Characterization of Ni/ZrTiAlO x Catalyst via Sol-Gel and Impregnation Methods for Low Temperature Dry Reforming of Methane.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.